ADAR1 Capital Management, LLC is 10% Owner at InMed Pharmaceuticals Inc. (INM). They have made 16 open-market trades across 5 companies since 2024, most recently 2026-10-15.
CIK 0001940272
16 open-market purchases totalling $11.7M since 2024, never a sale. Across 7 scored buys the stock is up 2.5% at ninety days, and 2.6 points behind the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RLYB | 926,352 | $15.3M |
| TENX | 6,524,151 | $8.9M |
| NXTC | 722,419 | $4.4M |
| PIRS | 129,574 | $1.8M |
| INM | 955,493 | $1.3M |
| Total | $31.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-15 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 67% | 57% |
| Avg Move | +5.6% | +6.2% | +2.5% |
| Alpha | +4.6% | +4.8% | -2.6% |
| Scored | 14 | 12 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INM | BUY | 2026-10-13 | 2026-10-15 | $1.33 | $13K | — | — | — |
| INM | BUY | 2026-10-06 | 2026-10-08 | $1.33 | $14K | — | — | — |
| INM | BUY | 2026-10-01 | 2026-10-05 | $1.33 | $57K | +0.8% | — | — |
| INM | BUY | 2026-09-14 | 2026-09-16 | $1.30 | $118K | -5.5% | — | — |
| TENX | BUY | 2026-09-03 | 2026-09-08 | $1.78 | $1.6M | -9.1% | -10.7% | — |
| TENX | BUY | 2026-08-31 | 2026-09-02 | $1.79 | $1.4M | -7.3% | +0.3% | — |
| TENX | BUY | 2026-08-20 | 2026-08-24 | $1.77 | $1.8M | -18.0% | -12.0% | — |
| NXTC | BUY | 2026-07-30 | 2026-08-03 | $4.93 | $1.5M | +74.2% | +57.4% | — |
| NXTC | BUY | 2026-07-27 | 2026-07-29 | $4.98 | $88K | +35.8% | +25.1% | — |
| INM | BUY | 2026-07-15 | 2026-07-17 | $1.56 | $2K | +6.7% | -6.4% | -14.1% |
| INM | BUY | 2026-05-19 | 2026-05-21 | $1.54 | $722K | -18.6% | -22.2% | -18.0% |
| RLYB | BUY | 2026-05-18 | 2026-05-20 | $13.98 | $227K | +9.0% | +7.3% | +14.8% |
| RLYB | BUY | 2026-05-13 | 2026-05-15 | $13.99 | $1.1M | +2.5% | +12.5% | +20.6% |
| RLYB | BUY | 2026-05-11 | 2026-05-13 | $14.00 | $711K | +6.3% | +13.2% | +14.1% |
| RLYB | BUY | 2026-05-04 | 2026-05-06 | $13.97 | $2.2M | -6.2% | +6.4% | +6.2% |
| PIRS | BUY | 2024-08-09 | 2024-08-12 | $15.39 | $92K | +8.3% | +3.0% | -5.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.